I think it is only a matter of time before Rap will have competitors - their lead on the market needed to be capitalised - maybe Pfizer can control this.
The Prof will know this and is hamstrung - he has no say where the company will now go.
Competitors will be learning from Raps mistakes - it is a shame such revolutionary technology is lost to Australia and we have no idea where Pfizer plans to take it AIMO
RAP Price at posting:
20.5¢ Sentiment: None Disclosure: Held
